Bullseye Asset Management’s bluebird bio BLUE Stock Holding History

Bullseye Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,188	Closed	-$5.05M	–	105
2021 Q2	$5.05M	Buy	12,188 +6,948	+133%	+$2.75M	1.7%	18
2021 Q1	$2.05M	Buy	5,240 +2,704	+107%	+$1.33M	0.76%	55
2020 Q4	$1.42M	Buy	2,536 +364	+17%	+$231K	0.53%	73
2020 Q3	$1.52M	Sell	2,172 -1	-0%	-$780	0.69%	58
2020 Q2	$1.72M	Buy	+2,173	New	+$1.64M	0.92%	42

Other funds holding BLUE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Bullseye Asset Management's BLUE Position: Q3 2021 in Review

Bullseye Asset Management sold out of bluebird bio (BLUE) in Q3 2021, closing a stake of 12,188 shares — an estimated $5.05M sold.

Bullseye Asset Management first reported a position in BLUE in Q2 2020 and held it in 5 quarters. The position peaked at $5.05M in Q2 2021. 196 funds tracked by Wall St. Rank hold BLUE as of Q3 2021.

Bullseye Asset Management reported no remaining bluebird bio position as of Q3 2021 after selling out during the quarter.
Bullseye Asset Management sold 12,188 bluebird bio shares in Q3 2021, an estimated $5.05M.
Bullseye Asset Management first reported a position in bluebird bio in Q2 2020 and held it in 5 quarters.
Bullseye Asset Management's bluebird bio position peaked at $5.05M in Q2 2021.
196 funds tracked by Wall St. Rank held bluebird bio as of Q3 2021.

Based on Bullseye Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.